MedTrace Logo

Evaluation of the Efficacy for Sentinel Lymph Node Policy in High-risk Endometrial Carcinoma

NCT03716414 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 78

Last updated 2020-06-23

No results posted yet for this study

Summary

To evaluate the efficacy of sentinel lymph node biopsy technique in patients with high-risk endometrial carcinoma, which provides the evidence that sentinel lymph node biopsy technique could substitute the systematic Lymph node dissection(LND).

Conditions

  • Endometrial Adenocarcinoma

Interventions

PROCEDURE

SLN mapping

Intra-operative SLN mapping with indocyanine green: Intracervical injection will be performed by the surgeon. Sub-mucous injections will be performed with 50% diluted dye at 3 and 9 o'clock positions. 1ml injection contained infracyanine green will be injected deeply into the stroma of the cervix (1cm-depth), and Arms Assigned Interventions another 1ml will be injected superficially (2mm-depth). The time between the injection and the search for SLN must be as soon as possible.

Sponsors & Collaborators

  • Fudan University

    lead OTHER

Principal Investigators

  • Chao Wang, Ph.D. · Obstetrics and Gynecology Hospital, Fudan University

  • Xuezhen Luo, Ph.D. · Obstetrics and Gynecology Hospital, Fudan University

  • Xiaojun Chen, Ph.D. · Obstetrics and Gynecology Hospital, Fudan University

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-01
Primary Completion
2020-02-16
Completion
2020-02-16

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03716414 on ClinicalTrials.gov